Mounjaro
Coverage of Mounjaro in the Nexus archive.
- Rosie O’Donnell says Mounjaro is part of why she’s ‘never felt better’ at 64
Rosie O'Donnell stated that she feels 'never better' at 64, crediting part of her improved health to Mounjaro, which was originally prescribed three years ago for diabetes management. She noted that she experienced unexpected weight loss and initially feared she had cancer after losing 12 pounds. The article also provides background information on Mounjaro (tirzepatide), noting it is a drug approved by the FDA for type 2 diabetes and chronic weight management.
- Eli Lilly beat earnings and raised its forecast as weight loss drug sales surged
Eli Lilly reported higher-than-expected earnings as revenue from its weight loss drugs Mounjaro and Zepbound surged, with Mounjaro revenue rising 91% to $9.9 billion and Zepbound generating $4.9 billion.
- Lilly’s revenue soars 48%, driven by demand for its GLP-1s
Lilly's revenue increased by 48% due to strong demand for its GLP-1 drugs Mounjaro and Zepbound, which are used for treating Type 2 diabetes and weight loss.
- Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly reported quarterly results that exceeded expectations, leading to an upward revision of its 2026 revenue forecast. The company now anticipates revenue between $85 billion and $87 billion for 2026, driven by strong sales of Zepbound and Mounjaro.
- I lost 4st on 'invisible Mounjaro': I thought it was too late for me in my 50s... then I discovered a method that works just like jabs - with no calorie counting or restrictions. It was so easy I felt guilty when people praised my willpower
A person in their 50s lost 4 stone using a weight loss method called 'invisible Mounjaro,' which mimics the effects of GLP-1 injections without requiring calorie counting or dietary restrictions. The method was described as effortless, leading to surprise at others' praise for their willpower.
- Grandmother, 73, developed sudden pain and died after increasing dose of her Mounjaro weight loss jab, inquest hears
A 73-year-old grandmother died after experiencing sudden pain following an increased dose of her Mounjaro weight loss injection, according to an inquest.
- Your brain may be wired to regain lost weight
The human brain evolved to protect body fat during scarcity, treating a higher weight as normal and triggering hunger and lower energy use after weight loss. Medications like Wegovy and Mounjaro can reduce appetite signals, though their effects may diminish when treatment stops.
- Which group achieves 41% more weight loss on GLP-1s like Mounjaro: study
A study found that one group achieved 41% more weight loss on GLP-1 drugs like Mounjaro compared to another group, with the difference attributed to gender. The research highlights a gender-based disparity in the effectiveness of Mounjaro, a blockbuster weight-loss medication.
- At 65, my GP warned me to lose my stores of visceral fat. I can't take Mounjaro and I'd tried every diet... then I found an eating plan to shed weight fast by eating MORE. Here's the exact way to lose 7lb in a week
A 65-year-old individual, unable to take Mounjaro, tried every diet to lose visceral fat but found success with an eating plan that involves eating more to lose weight quickly, shedding 7lb in a week.
- Rosie O'Donnell reveals how she avoided side effects during 65lb Mounjaro weight loss
Rosie O'Donnell shared her method for avoiding side effects during a 65-pound weight loss. She used Mounjaro to achieve this weight loss.
- Rosie O’Donnell breaks down exact Mounjaro dosage as she insists she’s ‘never’ had side effects
Rosie O’Donnell discussed her use of the weight-loss drug Mounjaro on the 'Bleep! With Ana Navarro' podcast, stating she takes it at a slow pace and claims to have never experienced side effects.
- Rosie O’Donnell breaks down exact Mounjaro dosage as she insists she’s ‘never’ had side effects
Rosie O’Donnell discusses her use of the weight-loss drug Mounjaro, stating she takes it at a slow pace and has never experienced side effects.
- NADINE DORRIES: There are two times of the year that threaten my new Mounjaro bikini body - and right now is one of them. Here's my cunning plan to keep the pounds off...
Nadine Dorries discusses two annual periods threatening her 'new Mounjaro bikini body' and outlines a strategy to maintain her weight. She shares a 'cunning plan' to prevent weight gain during these times.
- GLP-1 Microdosing: Risks, Benefits and What to Know Before Changing Your Dose
A growing trend of microdosing GLP-1 drugs like Ozempic and Wegovy is spreading via social media, with users altering doses to reduce costs and side effects. However, this practice lacks FDA approval and clinical testing, posing unpredictable health risks. Pharmacist Sue Ojageer warns that self-directed microdosing bypasses medical supervision and may not be safer than standard prescriptions.
- The $3 supplement that can turbo-charge your weight loss... and even outperform Mounjaro: Experts reveal eye-opening study that shows how drug-free pill can boost slimming by 600 per cent
A $3 supplement is claimed to enhance weight loss by 600% and outperform the drug Mounjaro, based on an expert-revealed study. The study suggests a drug-free pill could significantly boost slimming outcomes.
- I lost barely any weight on Wegovy AND Mounjaro despite hardly eating - it was a waste of £4K...I wish I'd tried the diet plan that actually worked sooner
A person reported minimal weight loss while using Wegovy and Mounjaro alongside restricted eating, spending £4,000 without success. They expressed regret for not trying an unnamed effective diet plan earlier.
- Novo Nordisk is asking a court to immediately block Eli Lilly's weight loss drug ads
Novo Nordisk is requesting a court to block Eli Lilly's advertisements for Zepbound and Mounjaro, alleging the ads use outdated data and fail to mention newer, higher-dose versions of Wegovy and Ozempic.
- The 75p supplement that can turbo-charge your weight loss... and even outperform Mounjaro: Experts reveal eye-opening study that shows how drug-free pill can boost slimming by 600 per cent
A 75p drug-free supplement is reported to boost weight loss by 600% and outperform the drug Mounjaro, according to an expert-revealed study. The study suggests the pill could significantly enhance slimming efforts without pharmaceutical intervention.
- Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
Australia’s Therapeutic Goods Administration (TGA) has issued warnings for diabetes and weight loss drugs like Ozempic, Wegovy, and Mounjaro, linking them to 36 cases of a rare but severe eye disorder called NAION that could cause blindness. The TGA updated product information to include this health risk.
- How GLP-1 drugs are reshaping how Americans shop for clothing
A ReturnPro survey indicates GLP-1 medications like Ozempic and Wegovy are altering clothing shopping habits in the U.S., with 71% of users buying more apparel due to changing sizes and 65% purchasing multiple sizes for returns. Men were nearly twice as likely as women to buy multiple sizes for returns, while psychological factors linked to the drugs may drive spending shifts toward clothing and wellness.
- I was hiding the shame of being a hard-working mother who drank and took cocaine. Then I took Mounjaro to lose weight... the effect on my humiliating habits was astonishing
A hard-working mother who concealed her drug use, including drinking and cocaine, tried Mounjaro for weight loss and experienced a significant positive change in her habits. The article highlights the unexpected impact of the medication on her previously stigmatized behaviors.
- Novo Nordisk sues Eli Lilly, alleging the company's GLP-1 ads are 'deliberately false'
Novo Nordisk sued Eli Lilly, alleging deceptive advertising claims about its weight-loss drug Zepbound compared to Novo Nordisk's Wegovy. The lawsuit claims Eli Lilly's ads use outdated clinical trials comparing different doses and mislead consumers into believing Zepbound is superior. Eli Lilly has defended its advertising and intends to contest the lawsuit.
- Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
Novo Nordisk is suing Eli Lilly over 'false and materially misleading' advertisements for its weight-loss and anti-diabetes treatments. The Danish pharmaceutical company alleges Eli Lilly is using outdated trial data to compare its highest doses against lower doses of Novo Nordisk's medicines.
- Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
Novo Nordisk is suing Eli Lilly, alleging that its TV and social media advertisements use outdated trial data to mislead consumers about the efficacy of weight loss drugs Zepbound and Mounjaro compared to rival injections.
- STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk sued Eli Lilly for allegedly running a deceptive ad campaign using outdated clinical trials to compare higher doses of its drugs Zepbound and Mounjaro with lower doses of Novo's Wegovy and Ozempic. The lawsuit, filed in New Jersey federal court, accuses Lilly of intentionally confusing consumers through misleading advertising.
- Mounjaro made me five stone lighter AND shed the awful hormone condition that's destroyed my life...but now I'm done with the jab
The article discusses an individual's experience with Mounjaro, which led to significant weight loss and improvement in a hormone condition, but they have since stopped using the treatment.
- Woman who spent years grabbing meals on the go as a taxi driver and tried countless failed diets showcases her incredible transformation after shedding 5 stone thanks to Mounjaro
A woman who worked as a taxi driver and struggled with failed diets lost 5 stone using Mounjaro. Her transformation highlights significant weight loss after years of on-the-go meals and diet attempts.
- Mounjaro left me ill and exhausted... and I piled weight on after quitting. Now I'm down 12lbs in just six weeks thanks to a simple healthy eating rule. It totally changed the way I think about food and my body
The individual experienced illness and weight gain after using Mounjaro but lost 12lbs in six weeks by adopting a simple healthy eating rule, which significantly changed their perspective on food and body.
- Mounjaro left me ill and exhausted... and I piled weight on after quitting. Now I'm down 12lbs in just six weeks thanks to a simple healthy eating rule. It totally changed the way I think about food and my body
A person reported becoming ill and exhausted while using Mounjaro, leading to weight gain after discontinuing it. They later lost 12 pounds in six weeks by adopting a simple healthy eating rule that changed their perspective on food and body.
- Summer styling rules if you're newly slim! I've dropped down to a size 8 after a decade of being overweight. Here's how to dress as a 60-year-old on Mounjaro to beat the summer heat and flash your legs: CLAUDIA CONNELL
Claudia Connell shares summer styling tips after losing weight to reach a size 8, having been overweight for a decade. She discusses dressing as a 60-year-old using Mounjaro to manage summer heat and showcase legs.
- At 49, with a disastrous menopausal waistline, I lost 6st on Mounjaro. But the real miracle? I've not put a pound back on since I stopped jabbing. Here's how YOU can get the same result
A 49-year-old individual lost 6 stone (84 pounds) using Mounjaro injections for menopausal weight gain and maintained the weight loss after discontinuing the treatment. The article claims others can achieve similar results.
- I used Mounjaro during my cancer treatment. Now doctors say the jabs could stop the disease coming back. This is what you need to know
A person used Mounjaro during cancer treatment, and doctors suggest the jabs could prevent the disease from recurring. The article highlights potential benefits of the medication in cancer care.
- Could Early Tirzepatide Alter the Course of Type 2 Diabetes?
2-year results from the SUPPRESS-EARLY trial indicate that early use of tirzepatide (Mounjaro, Zepbound) in type 2 diabetes management significantly improves outcomes. The findings were presented at the American Diabetes Association annual meeting.
- I lost 4st on Mounjaro, but my once thick and glossy hair was wrecked. I tried expensive shampoos and treatments but nothing worked. Then I started taking this supplement, with a wonder ingredient, and it's transformed my looks
A person lost 4 stone using Mounjaro but experienced significant hair thinning. Expensive hair treatments failed, but a supplement containing a specific ingredient improved their hair condition.
- Eli Lilly deploys weight-loss cash on ‘App Store’ for scientists
Eli Lilly, the maker of Mounjaro, is using funds from its weight-loss drug to develop an 'App Store' for scientists. The company is collaborating with small biotechs to leverage AI as a tool for drug discovery.
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza). The study evaluated their effectiveness in a head-to-head analysis.
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza).
- Which GLP-1 works best? New meta-study puts them head-to-head
A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza) to determine their effectiveness.
- The new GLP-1 generation: From daily tablets to new blockbuster fat jabs, these are the obesity medications that could soon be coming to the UK... and they're more affordable than Mounjaro
The new GLP-1 generation includes daily tablets and 'blockbuster fat jabs' for obesity treatment set to arrive in the UK, with claims of being more affordable than Mounjaro.
- Not all skinny: The French do get fat
France's healthcare system now reimburses anti-obesity drugs Wegovy and Mounjaro under strict conditions. The article discusses France's obesity rates and regional variations, while addressing the stereotype that French people don't get fat, noting it contains a partial truth compared to other EU nations.